{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:16:52Z","timestamp":1740107812051,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10157-022-02235-8","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T07:02:42Z","timestamp":1652943762000},"page":"955-962","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and histopathological features related to time to complete remission in adult-onset minimal change nephrotic syndrome patients with corticosteroid treatment"],"prefix":"10.1007","volume":"26","author":[{"given":"Fumiyuki","family":"Morioka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5302-3634","authenticated-orcid":false,"given":"Shinya","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kozo","family":"Nishide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Machiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Uedono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Ishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhito","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Emoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"2235_CR1","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s10157-015-1216-x","volume":"20","author":"S Nishi","year":"2016","unstructured":"Nishi S, Ubara Y, Utsunomiya Y, Okada K, Obata Y, Kai H, et al. Evidence-based clinical practice guidelines for nephrotic syndrome 2014. Clin Exp Nephrol. 2016;20:342\u201370.","journal-title":"Clin Exp Nephrol"},{"key":"2235_CR2","doi-asserted-by":"publisher","first-page":"e25845","DOI":"10.1097\/MD.0000000000025845","volume":"100","author":"Y Shimamura","year":"2021","unstructured":"Shimamura Y, Abe K, Maeda T, Ogawa Y, Takizawa H, Ishigami J, et al. Association between diuretic administration before diagnosis and incidence of acute kidney injury in patients with minimal change disease: a single-center observational study. Medicine (Baltimore). 2021;100:e25845.","journal-title":"Medicine (Baltimore)"},{"key":"2235_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003;362:629\u201339.","journal-title":"Lancet"},{"key":"2235_CR4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1080\/08860220600840165","volume":"28","author":"S Uezono","year":"2006","unstructured":"Uezono S, Hara S, Sato Y, Komatsu H, Ikeda N, Shimao Y, et al. Renal biopsy in elderly patients: a clinicopathological analysis. Ren Fail. 2006;28:549\u201355.","journal-title":"Ren Fail"},{"key":"2235_CR5","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s10157-012-0673-8","volume":"16","author":"H Yokoyama","year":"2012","unstructured":"Yokoyama H, Sugiyama H, Sato H, Taguchi T, Nagata M, Matsuo S, et al. Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol. 2012;16:903\u201320.","journal-title":"Clin Exp Nephrol"},{"key":"2235_CR6","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s10157-020-01864-1","volume":"24","author":"R Yamamoto","year":"2020","unstructured":"Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, et al. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS). Clin Exp Nephrol. 2020;24:526\u201340.","journal-title":"Clin Exp Nephrol"},{"key":"2235_CR7","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.ekir.2019.08.019","volume":"4","author":"GJ Oh","year":"2019","unstructured":"Oh GJ, Waldo A, Paez-Cruz F, Gipson PE, Pesenson A, Selewski DT, et al. Steroid-associated side effects in patients with primary proteinuric kidney disease. Kidney Int Rep. 2019;4:1608\u201316.","journal-title":"Kidney Int Rep"},{"key":"2235_CR8","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/ki.2012.280","volume":"82","author":"J Radhakrishnan","year":"2012","unstructured":"Radhakrishnan J, Cattran DC. The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines\u2013application to the individual patient. Kidney Int. 2012;82:840\u201356.","journal-title":"Kidney Int"},{"key":"2235_CR9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000167603","volume":"8","author":"SM Korbet","year":"1988","unstructured":"Korbet SM, Schwartz MM, Lewis EJ. Minimal-change glomerulopathy of adulthood. Am J Nephrol. 1988;8:291\u20137.","journal-title":"Am J Nephrol"},{"key":"2235_CR10","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s10157-013-0793-9","volume":"17","author":"M Shinzawa","year":"2013","unstructured":"Shinzawa M, Yamamoto R, Nagasawa Y, Oseto S, Mori D, Tomida K, et al. Age and prediction of remission and relapse of proteinuria and corticosteroid-related adverse events in adult-onset minimal-change disease: a retrospective cohort study. Clin Exp Nephrol. 2013;17:839\u201347.","journal-title":"Clin Exp Nephrol"},{"key":"2235_CR11","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.2215\/CJN.12331213","volume":"9","author":"M Shinzawa","year":"2014","unstructured":"Shinzawa M, Yamamoto R, Nagasawa Y, Oseto S, Mori D, Tomida K, et al. Comparison of methylprednisolone plus prednisolone with prednisolone alone as initial treatment in adult-onset minimal change disease: a retrospective cohort study. Clin J Am Soc Nephrol. 2014;9:1040\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2235_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10157-020-01992-8","volume":"25","author":"K Nishide","year":"2021","unstructured":"Nishide K, Nakatani S, Mori K, Morioka F, Machiba Y, Uedono H, et al. Clinical and histopathological features of acute kidney injury in adult-onset minimal change nephrotic syndrome. Clin Exp Nephrol. 2021;25:261\u20139.","journal-title":"Clin Exp Nephrol"},{"key":"2235_CR13","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1053\/j.ajkd.2016.10.032","volume":"69","author":"RJ Maas","year":"2017","unstructured":"Maas RJ, Deegens JK, Beukhof JR, Reichert LJ, Ten Dam MA, Beutler JJ, et al. The clinical course of minimal change nephrotic syndrome with onset in adulthood or late adolescence: a case series. Am J Kidney Dis. 2017;69:637\u201346.","journal-title":"Am J Kidney Dis"},{"key":"2235_CR14","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"2235_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2215\/CJN.03531006","volume":"2","author":"M Waldman","year":"2007","unstructured":"Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, et al. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol. 2007;2:445\u201353.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2235_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12882-018-0999-x","volume":"19","author":"A Fenton","year":"2018","unstructured":"Fenton A, Smith SW, Hewins P. Adult minimal-change disease: observational data from a UK centre on patient characteristics, therapies, and outcomes. BMC Nephrol. 2018;19:207.","journal-title":"BMC Nephrol"},{"key":"2235_CR17","doi-asserted-by":"publisher","first-page":"559.e1","DOI":"10.1016\/j.xkme.2020.05.011","volume":"2","author":"T Sasaki","year":"2020","unstructured":"Sasaki T, Tsuboi N, Marumoto H, Okabayashi Y, Haruhara K, Kanzaki G, et al. Nephron number and time to remission in steroid-sensitive minimal change disease. Kidney Med. 2020;2:559.e1-568.e1.","journal-title":"Kidney Med"},{"key":"2235_CR18","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/ndt\/gfg134","volume":"18","author":"KC Tse","year":"2003","unstructured":"Tse KC, Lam MF, Yip PS, Li FK, Choy BY, Lai KN, et al. Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses. Nephrol Dial Transplant. 2003;18:1316\u201320.","journal-title":"Nephrol Dial Transplant"},{"key":"2235_CR19","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/ki.1986.130","volume":"29","author":"F Nolasco","year":"1986","unstructured":"Nolasco F, Cameron JS, Heywood EF, Hicks J, Ogg C, Williams DG. Adult-onset minimal change nephrotic syndrome: a long-term follow-up. Kidney Int. 1986;29:1215\u201323.","journal-title":"Kidney Int"},{"key":"2235_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0272-6386(84)80081-5","volume":"3","author":"FJ Frey","year":"1984","unstructured":"Frey FJ, Frey BM. Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome. Am J Kidney Dis. 1984;3:339\u201348.","journal-title":"Am J Kidney Dis"},{"key":"2235_CR21","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1159\/000334360","volume":"34","author":"K Koike","year":"2011","unstructured":"Koike K, Tsuboi N, Utsunomiya Y, Kawamura T, Hosoya T. Glomerular density-associated changes in clinicopathological features of minimal change nephrotic syndrome in adults. Am J Nephrol. 2011;34:542\u20138.","journal-title":"Am J Nephrol"},{"key":"2235_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0002-9343(81)90754-3","volume":"70","author":"J Lowenstein","year":"1981","unstructured":"Lowenstein J, Schacht RG, Baldwin DS. Renal failure in minimal change nephrotic syndrome. Am J Med. 1981;70:227\u201333.","journal-title":"Am J Med"},{"key":"2235_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/BF00363905","volume":"295","author":"KM Koch","year":"1967","unstructured":"Koch KM, Dume T, Krause HH. Ochwadt B [intratubular pressure, glomerular capillary pressure and glomerular filtrate during mannitol diuresis]. Pflugers Arch Gesamte Physiol Menschen Tiere. 1967;295:72\u20139.","journal-title":"Pflugers Arch Gesamte Physiol Menschen Tiere"},{"key":"2235_CR24","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1053\/ajkd.2002.31400","volume":"39","author":"M Nakayama","year":"2002","unstructured":"Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, Fujimi S. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kidney Dis. 2002;39:503\u201312.","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-022-02235-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-022-02235-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-022-02235-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T12:08:11Z","timestamp":1663330091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-022-02235-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["2235"],"URL":"https:\/\/doi.org\/10.1007\/s10157-022-02235-8","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"type":"print","value":"1342-1751"},{"type":"electronic","value":"1437-7799"}],"subject":[],"published":{"date-parts":[[2022,5,19]]},"assertion":[{"value":"10 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors have conflicts of interests to declare in regard to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Institutional Review Board of Osaka City University Graduate School of Medicine approved the use of kidney biopsy specimens and clinical data in accordance with the Declaration of Helsinki and guidelines of the Osaka City University Graduate School of Medicine (Approval No. 2021\u2013155).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent for the kidney biopsy procedure was obtained from all individual patients included in the study. An opt-out option was given, as explained in instructions posted on the website of the institution.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}